Nasrat A. Hakim

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Northvale, NJ
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Nasrat A Hakim
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Nasrat A. Hakim

Form 4 holding CEO, President, Director, 10%+ Owner

ELITE PHARMACEUTICALS INC /NV/

Security class
Common Stock
Shares / value
216,649,250
Estimated value
$14,948,798
Report date
29 Mar 2024
Price
$0.0690
Ownership
Direct
Form 4 holding CEO, President, Director, 10%+ Owner

ELITE PHARMACEUTICALS INC /NV/

Security class
Common Stock
Shares / value
2,700,000
Estimated value
$186,300
Report date
29 Mar 2024
Price
$0.0690
Ownership
by IRA
Form 4 holding CEO, President, Director, 10%+ Owner

ELITE PHARMACEUTICALS INC /NV/

Security class
Common Stock
Shares / value
2,223,147
Estimated value
$153,397
Report date
29 Mar 2024
Price
$0.0690
Ownership
by Kristine Hakim

Insider Reports Filed by Nasrat A. Hakim

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .